FDA-Approved Heart Failure Treatment Secured By This Biotech Company

BioCardia Activates Recently FDA-Approved CardiAMP Heart Failure Phase 3 Pivotal Study.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

BioCardia, a leading biotechnology company in the field of regenerative medicine, has recently announced the activation of its Phase 3 Pivotal Study of the CardiAMP Heart Failure treatment. This study was rece…